Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Garima

      Articles By : Garima

      Purdue Pharma considers bankruptcy over OxyContin trial

      Purdue Pharma considers bankruptcy over OxyContin trial

      Garima16 March 2019 9:00 AM IST
      Connecticut-based Purdue Pharma's statement comes as the first trial date nears in hundreds of lawsuits aiming to hold the company and others in the...
      US: Woman with cancer who used JnJ talcum powder awarded Rs 200 crore approx

      US: Woman with cancer who used JnJ talcum powder awarded Rs 200 crore approx

      Garima15 March 2019 10:05 AM IST
      JnJ said it would appeal, citing "serious procedural and evidentiary errors" in the course of the trial, saying lawyers for the woman had...
      How will you pay Rs 3500 crore arbitral award to Daiichi: Supreme Court asks Singh Brothers

      How will you pay Rs 3500 crore arbitral award to Daiichi: Supreme Court asks Singh Brothers

      Garima15 March 2019 10:00 AM IST
      "Singh brothers were the flag bearers of the pharma care industry and it doesn't look good that you are appearing in court. Pay your debts and come...
      Hikma Pharma guides for injectables growth after profit surge

      Hikma Pharma guides for injectables growth after profit surge

      Garima15 March 2019 9:00 AM IST
      The Jordan-based, Hikma Pharma said its core operating profit rose to $460 million for the year ended Dec. 31 from $386 million a year earlier.New...
      Everstone acquires stake in Chennai based CPC Diagnostics

      Everstone acquires stake in Chennai based CPC Diagnostics

      Garima14 March 2019 4:59 PM IST
      The strategic partnership with Everstone Group will help CPC Diagnostics take its product portfolio to new customers and markets, the Chennai-based...
      CCI nod- Max Healthcare to merge with Radiant Life Care

      CCI nod- Max Healthcare to merge with Radiant Life Care

      Garima14 March 2019 11:39 AM IST
      According to the joint statement, the deal between KKR backed Radiant and Max Healthcare will see KKR becoming the majority shareholder, while Radiant...
      GE Healthcare announces Digital Collaboration with Amgen

      GE Healthcare announces Digital Collaboration with Amgen

      Garima14 March 2019 9:15 AM IST
      As a part of this initiative, GE Healthcare and Amgen will be installing a seamless connection for data transfer between GE Healthcare raw material...
      Biogen to sell biologics unit to Fujifilm for Rs 89 crore

      Biogen to sell biologics unit to Fujifilm for Rs 89 crore

      Garima14 March 2019 9:00 AM IST
      The Japanese company expects the acquisition of the Biogen unit Denmark Manufacturing ApS - equipped with six 15,000 litre bioreactors that make...
      Opioid litigation concerns weigh on pharmaceutical loan borrowers

      Opioid litigation concerns weigh on pharmaceutical loan borrowers

      Garima12 March 2019 9:00 AM IST
      NEW YORK: The opioid crisis came to the loan market last week, as the potential fallout from lawsuits weighed on manufacturers of the drugs cited as a...
      Banks agree to one time settlement with Sterling Biotech with 65 percent haircut

      Banks agree to one time settlement with Sterling Biotech with 65 percent haircut

      Garima11 March 2019 10:05 AM IST
      Mumbai: The lenders of Sterling Biotech Limited have agreed to a one-time settlement offer made by the promoters of the company and have decided to...
      Suven Life Sciences enters asset purchase agreement with Rising Pharma

      Suven Life Sciences enters asset purchase agreement with Rising Pharma

      Garima10 March 2019 11:00 AM IST
      Suven Life Sciences through its joint venture partner, Shore Suven Pharma, Inc has entered into a "stalking horse" asset purchase agreement to buy the...
      Side effects of Alnylam Givosiran raises concern, shares slip

      Side effects of Alnylam Givosiran raises concern, shares slip

      Garima10 March 2019 9:15 AM IST
      Alnylam said the drug, givosiran, met the main goal of reducing the yearly number of attacks in patients with acute intermittent porphyria (AIP) - a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok